Inventor · disambiguated record
Robin Steigerwald
Also filed as: STEIGERWALD ROBIN
26 granted patents·7 pending applications·14 citations·filing 2002–2023
93Inventor score
Top patents by PatentIndex Score
33 records- 0185US9463238B2Recombinant poxvirus vector comprising tetanus toxin fragment CBAVARIAN NORDIC AS·Filed 2012·Granted Oct 11, 2016·3 cites·19 claims
- 0283US8772023B2Promoters for recombinant viral expressionSTEIGERWALD ROBIN·Filed 2009·Granted Jul 8, 2014·6 cites·24 claims
- 0381US10072274B2Vector comprising multiple homologous nucleotide sequencesBAVARIAN NORDIC AS·Filed 2017·Granted Sep 11, 2018·1 cites·3 claims
- 0479US10881725B2Recombinant modified vaccinia virus Ankara (MVA) equine encephalitis virus vaccineBAVARIAN NORDIC AS·Filed 2017·Granted Jan 5, 2021·1 cites·27 claims
- 0574US10532094B2Recombinant modified vaccinia virus ankara (MVA) respiratory syncytial virus (RSV) vaccineBAVARIAN NORDIC AS·Filed 2018·Granted Jan 14, 2020·0 cites·17 claims
- 0674US2021196814A1Recombinant Modified Vaccinia Virus Ankara (MVA) Respiratory Syncytial Virus (RSV) VaccineBAVARIAN NORDIC AS·Filed 2021·Application pending·0 cites
- 0772US11918639B2Methods and compositions for inducing protective immunity against filovirus infectionBAVARIAN NORDIC AS·Filed 2021·Granted Mar 5, 2024·0 cites·10 claims
- 0872US10946089B2Recombinant modified vaccinia virus ankara (MVA) respiratory syncytial virus (RSV) vaccineBAVARIAN NORDIC AS·Filed 2020·Granted Mar 16, 2021·0 cites·18 claims
- 0971US11103570B2Recombinant modified vaccinia virus Ankara (MVA) foot and mouth disease virus (FMDV) vaccineBAVARIAN NORDIC AS·Filed 2016·Granted Aug 31, 2021·1 cites·10 claims
- 1070US11225673B2Stable recombinant MVA vectors comprising modified RSV genes with reduced intramolecular recombinatorial activityBAVARIAN NORDIC AS·Filed 2018·Granted Jan 18, 2022·0 cites·4 claims
- 1170US11173201B2Methods and compositions for inducing protective immunity against filovirus infectionBAVARIAN NORDIC AS·Filed 2019·Granted Nov 16, 2021·0 cites·8 claims
- 1269US10124058B2Recombinant modified vaccinia virus Ankara (MVA) Respiratory Syncytial Virus (RSV) vaccineBAVARIAN NORDIC AS·Filed 2017·Granted Nov 13, 2018·0 cites·18 claims
- 1369US9828414B2Pr13.5 promoter for robust T-cell and antibody responsesBAVARIAN NORDIC AS·Filed 2013·Granted Nov 28, 2017·1 cites·4 claims
- 1468US9480738B2Recombinant modified vaccinia virus ankara (MVA) respiratory syncytial virus (RSV) vaccineBAVARIAN NORDIC AS·Filed 2013·Granted Nov 1, 2016·0 cites·17 claims
- 1568US8999637B2Vector comprising multiple homologous nucleotide sequencesSTEIGERWALD ROBIN·Filed 2009·Granted Apr 7, 2015·0 cites·9 claims
- 1666US11571471B2Recombinant modified vaccinia virus ankara (MVA) equine encephalitis virus vaccineBAVARIAN NORDIC AS·Filed 2021·Granted Feb 7, 2023·0 cites·20 claims
- 1764US10561722B2Methods and compositions for enhancing immune responsesBAVARIAN NORDIC AS·Filed 2015·Granted Feb 18, 2020·1 cites·20 claims
- 1864US2021393766A1Recombinant Modified Vaccinia Virus Ankara (MVA) Foot and Mouth Disease Virus (FMDV) VaccineBAVARIAN NORDIC AS·Filed 2021·Application pending·0 cites
- 1962US9717787B2Recombinant modified vaccinia virus ankara (MVA) respiratory syncytial virus (RSV) vaccineBAVARIAN NORDIC AS·Filed 2016·Granted Aug 1, 2017·0 cites·22 claims
- 2061US11028130B2PR13.5 promoter for robust T-cell and antibody responsesBAVARIAN NORDIC AS·Filed 2017·Granted Jun 8, 2021·0 cites·8 claims
- 2161US9540660B2Vector comprising multiple homologous nucleotide sequencesBAVARIAN NORDIC AS·Filed 2015·Granted Jan 10, 2017·0 cites·8 claims
- 2260US2025387463A1Recombinant Modified saRNA (VRP) and Vaccinia Virus Ankara (MVA) Prime-Boost RegimenBAVARIAN NORDIC AS·Filed 2023·Application pending·0 cites
- 2358US11338030B2Multivalent recombinant modified vaccinia virus ankara (MVA) vector encoding filovirus immunogensBAVARIAN NORDIC AS·Filed 2020·Granted May 24, 2022·0 cites·12 claims
- 2453US2014342403A1Promoters for recombinant viral expressionBAVARIAN NORDIC AS·Filed 2014·Application pending·0 cites
- 2551US10561721B2Methods and compositions for inducing protective immunity against filovirus infectionBAVARIAN NORDIC AS·Filed 2015·Granted Feb 18, 2020·0 cites·12 claims
- 2650US2023233670A1A Recombinant Modified Vaccinia Virus (MVA) Vaccine Against Coronavirus DiseaseBAVARIAN NORDIC AS·Filed 2021·Application pending·0 cites
- 2749US10111946B2Poxviral vectors for low antibody response after a first priming immunizationBAVARIAN NORDIC AS·Filed 2013·Granted Oct 30, 2018·0 cites·17 claims
- 2846US10576141B2Recombinant modified vaccinia virus Ankara (MVA) multivalent filovirus immunogenic compositions and methods of useBAVARIAN NORDIC AS·Filed 2015·Granted Mar 3, 2020·0 cites·12 claims
- 2943US10653766B2Use of oil and water emulsions for increasing B cell responses with modified Vaccinia Ankara virusBAVARIAN NORDIC AS·Filed 2015·Granted May 19, 2020·0 cites·28 claims
- 3042US2017081642A1Recombinant poxvirus vector comprising tetanus toxin fragment cBAVARIAN NORDIC AS·Filed 2016·Application pending·0 cites
- 3141US9173933B2Recombinant modified vaccinia virus Ankara influenza vaccineWEIGL JOSEF·Filed 2011·Granted Nov 3, 2015·0 cites·20 claims
- 3240US10925956B2Methods and compositions for inducing protective immunity against a marburg virus infectionJANSSEN VACCINES & PREVENTION BV·Filed 2017·Granted Feb 23, 2021·0 cites·18 claims
- 3340US2004248238A1Method for increasing the solubility, expression rate and the acitivity of proteins during recombinant productionFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Robin Steigerwald files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →